InvestorsHub Logo
Followers 61
Posts 7546
Boards Moderated 2
Alias Born 02/10/2010

Re: Sanderson post# 40284

Friday, 08/06/2021 12:13:07 PM

Friday, August 06, 2021 12:13:07 PM

Post# of 43812
We're only talking about H&N cancer at this point because that's where the clinical trial actually has generated data.

It is quite likely (assuming that CVM does get FDA approval for H&N treatments) that other, similar types of cancer will start to get either treated off label, or even might get their own clinical trials. IMO - it's also likely that a similar improvement will be seen once that work is done.

By that time CVM will likely be generating a steady stream of revenue (again,... assuming H&N FDA approval) and can write their own (and our own) tickets for these studies, or license out making Multikine and focus the company on developing the LEAPS system further.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News